Jpmorgan Chase & CO Catalyst Pharmaceuticals, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 408,261 shares of CPRX stock, worth $8.77 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

408,261

Previous 374,373 9.05%

Holding current value

$8.77 Million

Previous $5.8 Million 39.96%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$15.19 - $21.35 $514,758 - $723,508	33,888 Added 9.05%	408,261 $8.12 Million
Q2 2024 Aug 12, 2024	SELL	$14.68 - $16.92 $1.5 Million - $1.73 Million	-102,047 Reduced 21.42%	374,373 $5.8 Million
Q1 2024 May 10, 2024	BUY	$13.18 - $17.11 $524,722 - $681,183	39,812 Added 9.12%	476,420 $7.59 Million
Q4 2023 Feb 12, 2024	BUY	$11.78 - $17.29 $19,919 - $29,237	1,691 Added 0.39%	436,608 $7.34 Million
Q3 2023 Nov 14, 2023	SELL	$11.69 - $15.02 $2.93 Million - $3.77 Million	-250,788 Reduced 36.57%	434,917 $5.08 Million
Q2 2023 Aug 11, 2023	SELL	$11.5 - $18.08 $754,952 - $1.19 Million	-65,648 Reduced 8.74%	685,705 $9.22 Million
Q1 2023 May 18, 2023	BUY	$14.34 - $21.05 $1.74 Million - $2.55 Million	121,214 Added 19.24%	751,353 $12.5 Million
Q1 2023 May 11, 2023	SELL	$14.34 - $21.05 $7.39 Million - $10.9 Million	-515,568 Reduced 45.0%	630,139 $10.4 Million
Q4 2022 Feb 13, 2023	SELL	$12.25 - $19.5 $2.26 Million - $3.59 Million	-184,285 Reduced 13.86%	1,145,707 $21.3 Million
Q3 2022 Nov 14, 2022	BUY	$7.06 - $15.52 $1.44 Million - $3.17 Million	204,159 Added 18.13%	1,329,992 $17.1 Million
Q2 2022 Aug 11, 2022	SELL	$6.23 - $8.57 $381,811 - $525,221	-61,286 Reduced 5.16%	1,125,833 $7.89 Million
Q1 2022 May 11, 2022	SELL	$5.31 - $8.31 $56,631 - $88,626	-10,665 Reduced 0.89%	1,187,119 $9.84 Million
Q4 2021 Feb 10, 2022	BUY	$5.21 - $7.45 $122,007 - $174,464	23,418 Added 1.99%	1,197,784 $8.11 Million
Q3 2021 Nov 12, 2021	BUY	$4.85 - $6.04 $5.7 Million - $7.09 Million	1,174,366 New	1,174,366 $6.22 Million

Others Institutions Holding CPRX

# of Institutions

327

Shares Held

94.6M

Call Options Held

19.1K

Put Options Held

51.1K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.21B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Catalyst Pharmaceuticals, Inc. Transaction History